湯臣倍健(300146.SZ)及子公司計提2019年度資產減值準備合計16.95億元
格隆匯3月12日丨湯臣倍健(300146.SZ)公佈,公司於2020年3月12日召開第四屆董事會第三十三次會議和第四屆監事會第十九次會議,審議通過了《關於計提2019年年度資產減值準備的議案》,公司及下屬子公司2019年度對各類資產計提的減值準備合計約16.95億元。
此次計提資產減值準備,將減少2019年歸屬於上市公司股東淨利潤約15.2億元,公司2019年歸屬於上市公司所有者權益相應減少約15.2億元。此次計提資產減值準備已經正中珠江會計師事務所(特殊普通合夥)審計確認。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.